Press release
At a CAGR of 41.58%, Global Antibody Conjugates Drugs Market is poised to grow during the period 2016-2020: Key Vendors are AbbVie, Ambrx, Agensys etc.
About Antibody Drug Conjugates
ADCs, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances. ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tissue.
Antibodies are the proteins produced by B-cells (from bone marrow) in the immune system. These proteins attach to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies that attach to different sites of an antigen. mAbs, complex proteins with high molecular weight, are monospecific as they are the clones of a single parent cell. They are of three types, chimeric, humanized, and fully human, and are often used for therapeutic and diagnostic purposes.
Technavios analysts forecast the global ADCs market to grow at a CAGR of 41.58% during the period 2016-2020.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=700592
Covered in this report
The report covers the present scenario and the growth prospects of the global ADCs market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of ADCs used to treat cancer.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Antibody Drug Conjugates Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Browse more details @ http://www.researchmoz.us/global-antibody-conjugates-drugs-market-2016-2020-report.html
Table of Content
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
Assumptions
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview of ADCs
Antibodies
Evolution of mAb therapeutics
Conjugated mAbs
History
Key components in ADCs
Next-generation ADCs
Advantages
Challenges
Outsourcing of ADCs manufacturing
Emergence of ADCs
Current marketed ADCs
PART 06: Pipeline portfolio
Information on pipeline candidates
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release At a CAGR of 41.58%, Global Antibody Conjugates Drugs Market is poised to grow during the period 2016-2020: Key Vendors are AbbVie, Ambrx, Agensys etc. here
News-ID: 632295 • Views: …
More Releases for ADCs
Application Delivery Controllers (ADCs) Market 2021 | Detailed Report
Application Delivery Controllers (ADCs) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Application Delivery Controllers (ADCs) Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5016520
The report provides a comprehensive analysis of company profiles listed below:
- A10 Networks…
Global Application Delivery Controllers (ADCs) Market 2020: key Vendors, Trends, …
Summary
A New Market Study, titled “Application Delivery Controllers (ADCs) Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
This report provides in depth study of “Application Delivery Controllers (ADCs) Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Application Delivery Controllers (ADCs) Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such…
Application Delivery Controllers (ADCs) Market Report by eSherpa Market Reports: …
The recently published report by eSherpa Market Reports on the global Application Delivery Controllers (ADCs) market provides a professional and an in-depth study presented on the market size, share, growth, trends, in addition to industry evaluation. Application Delivery Controllers (ADCs) Market report provides a precise analysis and competitive analysis of growth opportunities, trends, impending factors, and glaring drivers. Further, this study provides a possible forecast of the future market situation…
Antibody Drug Conjugates (ADCs) Market: In Depth Analysis on Market Growth & Key …
Interpretation of Antibody-Drug Conjugates: Antibody-drug conjugates are highly potent biopharmaceutical drugs designed for the treatment of people with cancer. ADCs have the ability to kill the cancer cells and combine the unique targeting nature of monoclonal antibodies with cytotoxic drugs. Antibody Drug Conjugates (ADCs) that are formed by monoclonal antibodies along with linkers and chemotherapy drugs are having better tumor targeting action with less toxic side effects than the traditionally…
Antibody Drug Conjugates (ADCs) Market Revenue, Growth Rates, and Industry Chall …
This report studies the global market size of Antibody Drug Conjugates (ADCs) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibody Drug Conjugates (ADCs) in these regions.
This research report categorizes the global Antibody Drug Conjugates (ADCs) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share,…
Global Antibody Drug Conjugates (ADCs) Therapeutics Market Size, Share, Developm …
The global antibody drug conjugates therapeutics market is expected to witness significant growth due to current unmet medical need of some chronic diseases such as cancer and immunological diseases, increasing prevalence of such diseases, advancement in technologies and high demand for safe and effective medication. The regulatory bodies are supporting the ADCs market by providing designations and funding for speeding up the drug development process. In April 2015, ImmunoGen, Inc.…
